Medical Cannabis Market 2019 Forecast Outlook by Pharmaceutical Companies, Medical Applications, Cannabinoids Product, Cannabis Revenue Growth & Regional Landscape

Medical Cannabis industry is still in its nascent stage & will develop significantly in the coming years. Increasing use of marijuana in therapeutic applications such as pain management in neurology, cancer, HIV/AIDS, seizures, & nausea will drive the medical cannabis market growth

Dallas, United States - August 14, 2019 /MarketersMedia/ —

The research report on ‘global medical cannabis market’ provides a detailed market analysis with market share and major players operating in the market. The report also covers the comprehensive outlook of technology, product specification, production analysis, and product type with the help of some key factors such as gross margin, cost, and revenue. The global medical cannabis market report offers in-depth study market segmentation depending on several regions. The report also contains the qualitative and quantitative analysis of market players.

Get Research Insights @ Global Medical Cannabis Market Research Report

Global medical cannabis market size is valued at US$ 7.26 billion from US$ 56.70 billion at a recorded CAGR of 29.3% over the forecast period. Increasing countries approving the utilization of cannabis, increasing edible products, and rising Research & Development activities are fueling the global medical cannabis market growth. In addition, rising growth of therapies with cannabis expected to drive the global medical cannabis market growth.

The global medical cannabis market segmentation is done with the help of indication and geographical regions. By indication, the global medical cannabis market is divided into neurological disease, pain management, and many others. However, the pain management segment is accounted for the highest global medical cannabis market share of 60%, and it is likely to dominate its growth over the forecast period. Many patients with lasting disorders need medical cannabis and it is anticipated to boost the global medical cannabis market growth during the prediction period. Likewise, medical cannabis shows positive results in number of chronic diseases such as Alzheimer’s, Parkinson’s, and Epilepsy.

Medical Cannabis Market Size by Indication (Pain Management, Neurological disorders, and others) by Region and Forecast 2016 to 2026 @ https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market

Based on regional landscape, the global medical cannabis market is sub-segmented into the North America, Asia Pacific, Europe, MEA, and Central & South America. In between these, the North America region dominated for the highest global medical cannabis market share over the forecast period. However, Canada and United States are major regions which authorized medical cannabis with maximum number of consumers. Increased awareness about medical usage and its benefits in chronic disease are projected to rise rapidly than the North American market.

North America dominates the global medical cannabis market by contributing over 90% of total revenue, of which majority comes from the U.S. Additionally, legalization in Canada is expected to grow at a faster CAGR compared to the U.S., on account of growth phase of Canadian market. The total number of patients using medical cannabis in Canada has increased in the past few quarters with corresponding increase in the number of licensed producers. This increase in number of medical cannabis users has led to a spike in revenues for companies. Such prevailing dynamics in the Canadian market is expected to attract investors in the coming years.

The global medical cannabis market is highly competitive owing to the large number of leading competitors playing in the market. These players are trying to stand their position in the global as well as local market. They use several strategies such as merger & acquisition, new product launches, and R&D activities. Some top players operating in this market are Maricann Group, Inc., Aphria, Inc., ABcann Medicinals, GW Pharmaceuticals, Organigram Holding, Inc., and Lexaria Corp.

Make an Enquire to Buy This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/864

Key Segments of the Global Medical Cannabis Market

Indication Overview, 2016-2026 (USD Billion)
• Pain Management
• Neurological Disease
• Others

Regional Overview, 2015-2025 (USD Million)
• North America
• U.S.
• Canada
• Europe
• Germany
• Spain
• Italy
• Asia Pacific
• Australia
• New Zealand
• Central & South America
• Mexico
• Uruguay
• Middle East & Africa

Buy the report @ https://www.adroitmarketresearch.com/researchreport/purchase/864

Major points from Table of Contents:

Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. Medical cannabis Market Overview, By Indication
Chapter 5. Key Country Market
Chapter 6. Company Profiles

Grasp advance knowledge on Global Medical Cannabis Industry through in-depth Blogs, White Paper & Infographics:

Access the Blog: “Medical Cannabis Helpful For Insomnia Patients

Across North America sleep disorders are very common now. Actually, many of the approximations are suggesting one in four Canadians suffering from insomnia, making it a common disorder of sleep.

Access the White Paper “All You Need To Know About Medical Cannabis

Recent United States Cannabis Research and Policy & Law Cannabis has validated health benefits since past few years. However, less than 6% of current studies on marijuana investigate its medical properties, periodicals to date specify that cannabis shows promise for the treatment of several diseases and symptoms. Though, patients with cancer and chronic pain, for ex. have been blocked from such benefits since the mid-20th century when government regulations were sanctioned that banned the sales, use, and distribution of cannabis due to its psychoactive properties.

About Adroit Market Research:

Adroit Market Research provide quantified B2B research on numerous opportunistic markets, and offer customized research reports, consulting services, and syndicate research reports. We assist our clients to strategize business decisions and attain sustainable growth in their respective domain. Additionally, we support them with their revenue planning, marketing strategies, and assist them to make decisions before the competition so that they remain ahead of the curve.

Contact Info:
Name: Ryan Johnson
Email: Send Email
Organization: Adroit Market Research
Address: 3131 McKinney Ave Ste 600 Dallas, TX 75204, U.S.A
Phone: +1 972-362 -8199
Website: https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market

Source URL: https://marketersmedia.com/medical-cannabis-market-2019-forecast-outlook-by-pharmaceutical-companies-medical-applications-cannabinoids-product-cannabis-revenue-growth-regional-landscape/88907320

Source: MarketersMedia

Release ID: 88907320

Latest News

Stocks rise as China confirms trade deal signing next week

Jun 2, 2020

NEW YORK — U.S stocks climbed in morning trading on Thursday as investors cheered confirmation from China that its top trade official will head to Washington next week to sign a preliminary trade deal. The “Phase 1” accord is the opening step on a possible path toward a broader agreement between the nations. President Donald Trump has said he will travel to Beijing after the initial signing to start the second stage of talks. Every major index is on track for a record as Wall Street distances itself from a bout of anxiety over the last week because of tensions...

Space Force will start small but let Trump claim a big win

Jun 2, 2020

WASHINGTON — The Trump administration is celebrating the launch of Space Force, the first new military service in more than 70 years. In signing the 2020 National Defense Authorization Act that includes Space Force, Trump on Friday can claim a victory for one of his top national security priorities just two days after being impeached by the House. It is part of a $1.4 trillion government spending package — including the Pentagon's budget — that provides a steady stream of financing for Trump's U.S.-Mexico border fence and reverses unpopular and unworkable automatic spending cuts to defense and domestic programs. Space...

House passes $1.4T government spending bill amid impeachment

Jun 2, 2020

WASHINGTON — The Democratic-controlled House voted Tuesday to pass a $1.4 trillion government spending package, handing President Donald Trump a victory on his U.S.-Mexico border fence while giving Democrats spending increases across a swath of domestic programs. The hard-fought legislation also funds a record Pentagon budget and is serving as a must-pass legislative locomotive to tow an unusually large haul of unrelated provisions into law, including an expensive repeal of Obama-era taxes on high-cost health plans, help for retired coal miners, and an increase from 18 to 21 in the nationwide legal age to buy tobacco products. The two-bill package,...

Stocks rise on Wall Street as rally stretches to fourth day

Jun 2, 2020

NEW YORK — U.S. stocks rallied Monday, rising with European and several Asian markets following surprisingly strong reports on China's economy. Growth in factory activity and retail sales in the world's second-largest economy both beat analysts’ expectations for last month. That layered on top of optimism from last week’s long-awaited “Phase 1” trade deal between China and the United States, which removed some of the uncertainty that’s hung over businesses and investors. The interim trade deal is one of a “trifecta of positive catalysts” that swept through the market last week and could help support it through the end of...

Wisconsin Senate to vote on firing agriculture secretary

Jun 2, 2020

MADISON, Wis. — Wisconsin's Republican-controlled Senate prepared Tuesday to fire the state agriculture secretary appointed by Democratic Gov. Tony Evers, the latest in a series of skirmishes between the governor and the GOP that comes as Wisconsin is losing dairy farmers at a record pace. Republicans and Evers have been fighting since before Evers even took office. Republicans convened a lame-duck session to pass laws weakening Evers' power in December. This summer, Evers used his expansive veto to reshape the GOP-passed state budget, resulting in attempts in court and through a constitutional amendment to weaken his veto authority. And on...

Search
Financial Markets

About Us

Established in 2015, The Upstocker provides insights on financial reports, commentary, and investment data to traders so that you can make better investment decisions.

Contact us: sales[at]theupstocker.com

Subscribe Now!